- Home
- SYTA vs NBY Comparison
SYTA vs NBY Comparison
Compare SYTA & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- NBY
- Stock Information
- Founded
- SYTA N/A
- NBY 2000
- Country
- SYTA Canada
- NBY United States
- Employees
- SYTA N/A
- NBY N/A
- Industry
- SYTA Telecommunications Equipment
- NBY
- Sector
- SYTA Telecommunications
- NBY
- Exchange
- SYTA Nasdaq
- NBY Nasdaq
- Market Cap
- SYTA 3.1M
- NBY 2.8M
- IPO Year
- SYTA 2020
- NBY 2007
- Fundamental
- Price
- SYTA $3.23
- NBY $0.63
- Analyst Decision
- SYTA
- NBY Strong Buy
- Analyst Count
- SYTA 0
- NBY 1
- Target Price
- SYTA N/A
- NBY $0.85
- AVG Volume (30 Days)
- SYTA 240.3K
- NBY 107.9K
- Earning Date
- SYTA 04-07-2025
- NBY 03-25-2025
- Dividend Yield
- SYTA N/A
- NBY N/A
- EPS Growth
- SYTA N/A
- NBY N/A
- EPS
- SYTA N/A
- NBY N/A
- Revenue
- SYTA $11,988,979.00
- NBY $13,844,000.00
- Revenue This Year
- SYTA $75.92
- NBY N/A
- Revenue Next Year
- SYTA $19.72
- NBY $11.73
- P/E Ratio
- SYTA N/A
- NBY N/A
- Revenue Growth
- SYTA 41.59
- NBY 15.40
- 52 Week Low
- SYTA $3.04
- NBY $0.07
- 52 Week High
- SYTA $885.60
- NBY $6.30
- Technical
- Relative Strength Index (RSI)
- SYTA 30.99
- NBY 44.89
- Support Level
- SYTA $3.04
- NBY $0.61
- Resistance Level
- SYTA $5.40
- NBY $0.71
- Average True Range (ATR)
- SYTA 0.49
- NBY 0.05
- MACD
- SYTA -0.06
- NBY -0.01
- Stochastic Oscillator
- SYTA 8.05
- NBY 27.27
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.